Safety and Efficacy of IDP-122 in the Treatment of Participants With Plaque Psoriasis
Status:
Completed
Trial end date:
2017-03-15
Target enrollment:
Participant gender:
Summary
This study is to evaluate the safety and efficacy of a topical lotion when applied once daily
to adult participants with moderate to severe plaque psoriasis (defined as an Investigator's
Global Assessment [IGA] score of 3 or 4).
Phase:
Phase 3
Details
Lead Sponsor:
Bausch Health Americas, Inc. Valeant Pharmaceuticals International, Inc.